VERTEX PHARMACEUTIC
VERTEX PHARMACEUTIC operates in Diversified Metals & Mining.
VERTEX PHARMACEUTIC - Asset Resilience Ratio
VERTEX PHARMACEUTIC (VX1) has an Asset Resilience Ratio of 5.78% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how VERTEX PHARMACEUTIC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down VERTEX PHARMACEUTIC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €1.29 Billion | 5.78% |
| Total Liquid Assets | €1.29 Billion | 5.78% |
Asset Resilience Insights
- Limited Liquidity: VERTEX PHARMACEUTIC maintains only 5.78% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
VERTEX PHARMACEUTIC Industry Peers by Asset Resilience Ratio
Compare VERTEX PHARMACEUTIC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT |
Other | 0.00% |
|
TV BROADCAST
MU:TBCN |
Other | 2.06% |
|
FIRST CITIZENS BC A
BE:FC6A |
Other | 12.78% |
|
COSTCO WHSL
MU:CTO |
Other | 1.77% |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS |
Other | 1.39% |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO |
Other | 0.43% |
Annual Asset Resilience Ratio for VERTEX PHARMACEUTIC (2016–2023)
The table below shows the annual Asset Resilience Ratio data for VERTEX PHARMACEUTIC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 3.74% | €849.20 Million | €22.73 Billion | +2.22pp |
| 2022-12-31 | 1.51% | €274.50 Million | €18.15 Billion | -3.92pp |
| 2021-12-31 | 5.43% | €729.90 Million | €13.43 Billion | -0.27pp |
| 2020-12-31 | 5.71% | €670.70 Million | €11.75 Billion | -2.70pp |
| 2019-12-31 | 8.40% | €698.97 Million | €8.32 Billion | +0.11pp |
| 2018-12-31 | 8.30% | €518.11 Million | €6.25 Billion | -3.64pp |
| 2017-12-31 | 11.94% | €423.25 Million | €3.55 Billion | +3.28pp |
| 2016-12-31 | 8.65% | €250.61 Million | €2.90 Billion | -- |